Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib Study of the Safety and Pharmacology of Atezolizumab Administered With Cobimetinib in Patients With Locally Advanced or Metastatic Solid Tumors

NCT01988896 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01988896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01988896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib Study of the Safety and Pharmacology of Atezolizumab Administered With Cobimetinib in Patients With Locally Advanced or Metastatic Solid Tumors
Lead sponsor
Hoffmann-La Roche
Phase
Phase 1
Overall status
Completed
Start date
December 27, 2013
Completion date
November 4, 2019
Enrollment
153 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors